Ruohao Xu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Genomic characterisation of Chinese myeloid malignancies and its clinical correlates: insights from targeted next-generation sequencing.
Journal: Frontiers in medicine
Published: December 22, 2025
MRD-driven HDACi-based therapy post-transplant: a real-world study in high-risk acute myeloid leukemia.
Journal: Annals of hematology
Published: November 20, 2025
TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia.
Journal: Acta haematologica
Published: December 18, 2023
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 21, 2022
Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment.
Journal: Frontiers in immunology
Published: May 22, 2022
Hypomethylating agents in the treatment of chronic myelomonocytic leukemia: a meta-analysis and systematic review.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 12, 2021
Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center.
Journal: American journal of cancer research
Published: December 02, 2020
Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
Journal: British journal of haematology
Published: November 01, 2020
Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAs.
Journal: American journal of translational research
Published: February 13, 2019
A retrospective study comparing azacitidine with decitabine in Chinese patients with refractory anemia with excess blast based on two clinical trials in a single center.
Journal: American journal of translational research
Published: January 21, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026